Vitamin B12 Neuropathy: Why a Normal Level Can Miss It

Numb feet with a burning floor beneath them, a gait that has turned careful, and a chart that says idiopathic. For many people in chronic nerve pain, vitamin B12 neuropathy is already sitting in that chart, hidden behind a blood level someone stamped normal. The video version of Chapter 6 of The Angry Gut, The Normal B12 That Wasn’t, tells the case that taught me to stop trusting that stamp. Here I follow the nerve: why it starves, which medications speed that up, and what a pain practice should order before it reaches for another label.

A normal result and a man losing his footing

He was seventy-one, ate well, and was fading. Numbness had climbed from his soles to mid-calf. His wife noticed he repeated himself. A nerve conduction study confirmed a length-dependent sensory neuropathy and explained nothing, and his serum B12 came back at 348, which he was told was fine. His methylmalonic acid, the metabolite that builds up when B12 fails inside cells, was frankly high. His stomach had almost no parietal cells left.

Nerve testing tells you a nerve is failing. It does not tell you why, which is the whole argument behind what nerve testing actually measures. The why here sat upstream of the nerve, in the first brain.

How vitamin B12 neuropathy begins in the stomach

Getting B12 out of food and into a nerve takes more steps than any other nutrient. Acid frees it from food protein. Pancreatic enzymes pass it to intrinsic factor, a protein made only by the parietal cells of the stomach lining. That package rides the entire small bowel to a receptor at its far end, and bile recycles part of it for a second pass. Every link lives in the gut, the first brain, tethered by the vagus to the second brain in the skull. Break one link and the long nerves of the legs and the spinal cord go hungry slowly, over years.

I was taught that stomach acid fades with birthdays, and I passed that on to patients. The measurements disagree. Acid output does look about 30% lower in older people, but once gastritis and H. pylori infection are accounted for, age has no independent effect. In 248 community-dwelling older adults, 84% had acidic stomachs. What wrecks the lining is infection and autoimmunity. Carrying H. pylori multiplies the rate of new atrophic gastritis about 5.0 times, and atrophic gastritis is present in up to 15% of Americans.

The stereotype of who gets the autoimmune form fails too. In a Miami biopsy series with many Hispanic patients, prevalence was 4.6%, against 1.1% in a mostly White Baltimore series. Of the 79 Miami cases, 76.0% were Hispanic. Screen only older Northern European women and most of the nerve damage walks out the door undiagnosed.

The prescriptions that drain the nerve supply

Metformin is the drug to understand, and it earns its place as first-line therapy for type 2 diabetes. In a Dutch randomized placebo-controlled trial over 4.3 years, it produced an absolute excess of frank B12 deficiency of 7.2 percentage points, a number needed to harm of 13.8. The borderline band widened by 11.2 points, a number needed to harm of 8.9. Homocysteine tracked it, at 23.7 µmol/l in patients deficient at the end against 14.9 in those with normal B12, so the chemistry downstream really changed.

Longer follow-up sharpens the nerve question. In the Diabetes Prevention Program, 1,073 people on metformin were compared with 1,082 on placebo. Low or borderline B12, at or below 298 pg/mL, ran 19.1% against 9.5% at five years, and neuropathy was more common on metformin only among participants whose B12 was low. In an American database of 14,808 adults with type 2 diabetes, long-term users had a 67% higher likelihood of deficiency than non-users, yet the neuropathy difference against non-users was not significant. That is what you would expect if years of diabetes, and not only the drug, were grinding the nerve down.

So hold both drivers at once. Metformin lowers B12. Diabetes injures nerves on its own, as anyone with diabetic nerve pain that burns at night already knows. Do not stop the drug on your own; take the question to your physician.

Acid blockers are the second prescription. Two or more years of proton pump inhibitor supply carries an odds ratio of 1.65 for B12 deficiency, and among those users, more than 1.5 pills a day carries 1.95. H2 blockers alone carry 1.25. Chapter 20, The Heartburn Pill You Can’t Quit, is about why those prescriptions so often outlive their reason. Gastric bypass is the third: pooled randomized trials put its risk of B12 deficiency at 1.86 times that of sleeve gastrectomy, with no difference in iron or folate, which is exactly what losing intrinsic factor predicts.

Nitrous oxide and the young nerve

The fastest-growing version of this neuropathy skips the stomach entirely. Recreational nitrous oxide leaves the blood level looking fine while the vitamin stops working. In a French neurology cohort of 41 patients injured by it, serum B12 was normal in most, while raised homocysteine and methylmalonic acid confirmed a functional deficiency. A sensorimotor axonal neuropathy was found in 78.4%, most often a motor-dominant, length-dependent pattern in the legs alongside spinal cord involvement. With suspected nitrous oxide exposure, neither total B12 nor holotranscobalamin is useful; plasma homocysteine is the first test, often above 50 µmol/L. The behavioral fix is total: stop the gas.

What a pain practice orders before another label

Total serum B12 is the wrong single test for a failing nerve. In patients with megaloblastic anemia, measured against methylmalonic acid, it identified only 63% of deficient cases, and it reads falsely normal in people with high-titer intrinsic factor antibodies. So for burning, numb or unsteady feet with no clear cause, the sequence is functional first: methylmalonic acid or holotranscobalamin, homocysteine where nitrous oxide is possible, both gastric antibodies rather than one, and an honest look at kidney function before reading any of it.

Large red blood cells are not a trigger worth waiting for. Macrocytosis is a late and nonspecific sign, and some deficient patients show a normal blood count. When antibodies and chemistry point at the stomach, the stomach deserves a look. In an Italian network of 1,598 patients with autoimmune gastritis, neuroendocrine tumors occurred in 9.6%, and a B12 or iron deficiency at diagnosis carried a hazard ratio of 16.44 for them.

Then the route. A review that argues hard for tablets still carves out symptomatic patients with severe neurologic deficits for injection, to refill stores before damage becomes permanent. The oral trial usually quoted for equal neurologic recovery rested on 4 patients on tablets and 4 on injections. My patient went on injections because the machinery that makes tablets reliable was gone. Eleven months later he walked more steadily and was back in conversations. Some of what he lost did not return, and that is the real price of a normal-looking number.

One nerve, a collision of epidemics

This is where the silo breaks. Two biological drivers, an inflamed or autoimmune stomach and a sugar-damaged nerve, converge on one patient. The third driver is economic: we subsidize the calories that cause the diabetes, the diabetes earns the metformin, the metformin draws down the vitamin, and the single test on the order set cannot see it.

What returns agency is terrain work with a physiological reason behind it. Insulin resistance is what put most of these patients on metformin, so food, sleep and resistance training that lower insulin reduce the metabolic pressure on the nerve and on the prescription together. Any change to a medication belongs with your physician. A failing lining also rarely runs short of one thing: in a biopsy series of 122 patients with autoimmune gastritis, 76 had at least one deficiency among B12, iron, vitamin D and folate. That is why the quiet deficiencies that drive nerve pain get checked together.

For the full evidence, with every study’s numbers and what each does not show, open the Chapter 6 Deep Dive, the complete study-by-study file with questions for your physician. The series runs from Chapter 5, The Alcohol You Never Drank, to Chapter 7, on the raw materials the gut wall is built from.

Frequently asked questions

Can low B12 cause nerve pain even with a normal blood test?

Yes. A standard B12 assay mostly counts vitamin bound to a carrier that never enters cells, and it reads falsely normal in people with high intrinsic factor antibodies. Methylmalonic acid or homocysteine show whether B12 is actually working. Burning or numb feet carrying an idiopathic label deserve those functional tests. Read why neuropathy so often goes undiagnosed.

Does metformin cause B12 deficiency?

It lowers B12 in many people. In a randomized placebo-controlled trial over 4.3 years, metformin cut serum B12 by 19%, adding one case of frank deficiency for roughly every fourteen patients treated. Metformin remains a valuable diabetes drug, so the answer is monitoring with the right test, not stopping it on your own. See how insulin resistance builds years before diabetes.

Is nerve damage from B12 deficiency reversible?

Partly, and timing decides how much. Blood counts and neurologic signs can improve promptly once stores are refilled, but damage that has matured may not fully return. That is why symptomatic patients with significant neurologic deficits are generally started on injections, to replace stores quickly. The earlier a functional deficiency is found, the more nerve is left to save. Learn why normal test results can still come with real pain.

Can nitrous oxide cause neuropathy?

Yes. Recreational nitrous oxide disables B12 while the blood level often stays normal. In a French neurology cohort, a sensorimotor axonal neuropathy was found in 78.4% of patients injured by it, often with spinal cord involvement. Homocysteine, not serum B12, is the first test to order, and stopping the exposure is not optional. Compare other causes of burning in the sole of the foot.

Are B12 shots better than pills for neuropathy?

It depends on the stomach. About 1% of an oral dose crosses the gut wall without intrinsic factor, so very high-dose tablets can work where the lining still functions. Where autoimmune gastritis has destroyed the parietal cells, or nerves are already damaged, injections replace stores faster and more reliably. Work out the route with your physician based on the cause. See why we treat insulin before we treat the joint.

Sources

1. de Jager, J., Kooy, A., Lehert, P., Wulffelé, M. G., van der Kolk, J., Bets, D., Verburg, J., Donker, A. J. M., & Stehouwer, C. D. A. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomised placebo controlled trial. BMJ, 340, c2181. https://doi.org/10.1136/bmj.c2181
2. Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., & Crandall, J. P. (2016). Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. The Journal of Clinical Endocrinology and Metabolism, 101(4), 1754-1761. https://doi.org/10.1210/jc.2015-3754
3. Sepassi, A., Wang, J., Yankowski, S., Enkoji, A., Okenwa, M., Morello, C. M., & Hurley-Kim, K. (2025). Associations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: An All of Us Research Program study. Diabetes Research and Clinical Practice, 228, 112424. https://doi.org/10.1016/j.diabres.2025.112424
4. Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013). Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA, 310(22), 2435-2442. https://doi.org/10.1001/jama.2013.280490
5. Boulin, F., Bédat-Millet, A.-L., Didier-Laurent, A., Louillet, F., Quesney, G., Hébant, B., Sudrié-Arnaud, B., Maltête, D., Welter, M. L., Guyant-Maréchal, L., & Zourdani, L. (2025). Neurological damage from recreational nitrous oxide use: Two distinct electroclinical profiles in a retrospective cohort. Revue Neurologique, 181(8), 742-747. https://doi.org/10.1016/j.neurol.2025.07.002
6. Harrington, D. J., Stevenson, E., & Sobczyńska-Malefora, A. (2024). The application and interpretation of laboratory biomarkers for the evaluation of vitamin B12 status. Annals of Clinical Biochemistry, 62(1), 22-33. https://doi.org/10.1177/00045632241292432
7. Tufail, N., Kataria, M., Chaudhary, A. J., Dhillon, R. A., Asif Naveed, M., & Mohsin, S. (2024). Comparing holotranscobalamin and total vitamin B12 in diagnosing vitamin B12 deficiency in megaloblastic anemia patients. Cureus, 16(10), e71278. https://doi.org/10.7759/cureus.71278
8. Lenti, M. V., Miceli, E., Lahner, E., Natalello, G., Massironi, S., Schiepatti, A., Zingone, F., Sciola, V., Rossi, R. E., Cannizzaro, R., De Giorgi, E. M., Gregorio, V., Fazzino, E., Gentile, A., Petrucci, C., Dilaghi, E., Pivetta, G., Vanoli, A., Luinetti, O., … Di Sabatino, A. (2024). Distinguishing Features of Autoimmune Gastritis Depending on Previous Helicobacter pylori Infection or Positivity to Anti-Parietal Cell Antibodies: Results From the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO). The American Journal of Gastroenterology, 119(12), 2408-2417. https://doi.org/10.14309/ajg.0000000000002948
9. Chan, C. Q. H., Low, L. L., & Lee, K. H. (2016). Oral vitamin B12 replacement for the treatment of pernicious anemia. Frontiers in Medicine, 3, 38. https://doi.org/10.3389/fmed.2016.00038
10. Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021). AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review. Gastroenterology, 161(4), 1325-1332.e7. https://doi.org/10.1053/j.gastro.2021.06.078

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 6 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP